Co-Authors
This is a "connection" page, showing publications co-authored by AMY MCGUIRE and DAVID MATHAI.
Connection Strength
1.961
-
Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with obsessive-compulsive disorder: international findings from the LATINO Study. Braz J Psychiatry. 2026; 48:e20254316.
Score: 0.936
-
Integrating evidence, subject-matter expertise, and consensus in Delphi-based clinical guideline development. J Affect Disord. 2026 Jul 20; 414:122288.
Score: 0.247
-
Interdisciplinary, Delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3). J Affect Disord. 2026 Oct 15; 411:121970.
Score: 0.244
-
From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care. Transl Behav Med. 2026 Jan 07; 16(1).
Score: 0.239
-
Reported Safety Practices of Publicly Advertised Psychedelic Retreats. JAMA Netw Open. 2026 01 02; 9(1):e2552505.
Score: 0.238
-
On Minimizing Risk and Harm in the Use of Psychedelics. Psychiatr Res Clin Pract. 2025; 7(1):4-8.
Score: 0.056